Takeda

CINRYZE - Cost

Last Updated: April 1st, 2024

HCPCS:

J0598

HCPCS Code Descriptor:

Injection, c-1 esterase inhibitor (human), cinryze, 10 units

Medicare Payment Limit:

The CINRYZE Medicare Payment Limit is $62.562

Average Sale Price:

CINRYZE ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The CINRYZE Medicare Co-insurance percentage is 20%. CINRYZE's Medicare Co-insurance amount is $12.51 per HCPCS unit.

APC Code:

The Cinryze APC Code is: 9251

APC Payment Limit:

The APC Payment Limit for CINRYZE is available. Login to view.

Cinryze Cost Information:

CINRYZE, manufactured by Takeda, became effective on January 1, 2011, and is aligned to HCPCS J0598. Between 2022 and 2024, prices trended upwards with slight increases of a couple percentage points every year. WAC and ASP remain close through 2024 signifying marginal discounting.

ACCESS PRICING AND MORE BY REGISTERING

Cinryze’s wholesale acquisition cost (WAC) information was last updated on:
January 1, 2024
Cinryze’s average wholesale price (AWP) information was last updated on:
January 1, 2024